fluorodeoxyglucose f18 has been researched along with gw9662 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheong, SJ; Jeong, HJ; Kim, EM; Lee, CM; Lim, ST; Sohn, MH | 1 |
| Cai, Q; Huang, G; Li, W; Li, Z; Liu, W; Meng, X; Wang, S; Zhang, D; Zhang, X; Zhang, Y; Zheng, Y | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and gw9662
| Article | Year |
|---|---|
The effect of PPAR-γ agonist on (18)F-FDG PET imaging for differentiating tumors and inflammation lesions.
Topics: Anilides; Animals; Biological Transport; Cell Line, Tumor; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Inflammation; Macrophages; Mice; Neoplasms; Pioglitazone; Positron-Emission Tomography; PPAR gamma; Thiazolidinediones; Tissue Distribution | 2015 |
Intranasal 15d-PGJ2 ameliorates brain glucose hypometabolism via PPARγ-dependent activation of PGC-1α/GLUT4 signalling in APP/PS1 transgenic mice.
Topics: Administration, Intranasal; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Anilides; Animals; Behavior, Animal; Brain; Cytokines; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 4; Hippocampus; Immunologic Factors; Mice; Mice, Transgenic; Morris Water Maze Test; Neurons; Peptide Fragments; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Positron-Emission Tomography; PPAR gamma; Presenilin-1; Prostaglandin D2; Radiopharmaceuticals; Signal Transduction | 2021 |